Agena, Horizon Discovery Partner on Oncology Assay Reference Standards

Apr 14, 2016

|

NEW YORK (GenomeWeb) – Agena Bioscience and Horizon Discovery announced today that they have signed an agreement to incorporate Horizon's human genomic reference standards into oncology-based assays run on Agena's MassArray system.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Getting It Early

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Food Bugs to Meet Sequencers

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

From Ancient Bathrooms

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

This Week in Nature

In Nature this week: ash dieback disease fungal genome, and more.

Featured White Papers

Accurate QC Analysis of cfDNA with the Fragment Analyzer

Detect low-level somatic mutations in FFPE samples using an extended RAS research assay

InnoStamp 40 and InnoScan 1100AL: a complete automated platform for microstructured cell arrays

Albumin Removal Reference Applications

May

01

Featured Webinar

Analytical Validation of a Liquid Biopsy Assay for High-Sensitivity Molecular Profiling

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May

08

Featured Webinar

Structural Variation Detection by Proximity Ligation from FFPE Tumor Tissue

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.

May

22

Featured Webinar

From Qualitative to Quantitative: Experiences with a cfDNA Assay in Metastatic Breast Cancer Research

In this webinar, the third in the “New Frontiers in Liquid Biopsy Research” series, Dr. Liya Xu of the University of Southern California Michelson Center for Convergent Biosciences will discuss her team’s work using liquid biopsy technology for breast cancer research.

Jun

12

Featured Webinar

Bridging the Gap Between Testing and Treatment in Precision Oncology

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Main menu